Loading clinical trials...
Loading clinical trials...
This study aims to determine the efficacy of nebulising 3% hypertonic saline in improving clinical symptoms and reducing the length of hospital stay in infants with acute bronchiolitis.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Can Tho University of Medicine and Pharmacy
NCT06321133 · Acute Bronchiolitis
NCT07346963 · Respiratory Syncytial Virus Infection, Acute Bronchiolitis Due to Respiratory Syncytial Virus, and more
NCT06689631 · Acute Bronchiolitis Due to Respiratory Syncytial Virus, Bronchiolitis Acute, and more
NCT04519073 · Acute Bronchiolitis Due to Respiratory Syncytial Virus
NCT04613180 · Acute Bronchiolitis
Can Tho Children's Hospital
Can Tho
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions